QR Group explains the main changes and guides companies on how to maintain compliance safely and quickly

In April 2024, ANVISA published the new Normative Instruction (IN) No. 280/2024, which changes relevant aspects of the regulation of cosmetics and personal care products in Brazil. The measure updates the technical requirements for regularization, with a focus on security, clarity and greater agility in the analysis and commercialization processes.

QR Group, a specialist in health and wellness product regulation, analyzes the main impacts of the new rules and guides companies in the sector to adapt safely and efficiently.

What changes with IN No. 280/2024?

The new regulation repeals and replaces the old IN No. 64/2020, with significant updates in points such as:

• Lists of allowed, restricted and prohibited substances in cosmetics;

• Update of international technical references, such as those of the European Union;

• Greater clarity in the classification of products by degree of risk (Grade 1 or Grade 2);

• Possibility of continuous updating via new ANVISA communications.

These changes aim to harmonize Brazilian requirements with international standards, without giving up consumer safety.

Impacts on companies in the cosmetics sector

With the new rules, companies will need to review their products and internal processes to ensure compliance with the updated criteria. Key points of attention include:

• Verification of formulations and labeling based on the new ingredient lists;

• Reclassification of products that may have their degree of risk altered;

• Update of technical dossiers and notifications already filed;

• Adaptation of new releases to the current standard.

Failure to align with the new requirements may result in notifications, recalls and blocking of the sale of products.

How QR Group helps companies adapt to the new regulation

QR Group offers complete support to companies that work with cosmetics, ensuring regulatory compliance, risk reduction and agility in processes with ANVISA:

• Technical review of portfolio and ingredients, based on IN No. 280/2024;

• Correct classification of the degree of risk and guidance on notifications or records;

• Preparation and updating of technical dossiers according to the new requirements;

• Complete monitoring of processes with ANVISA.

Our team of experts ensures clear and strategic technical solutions, so that your company can focus on innovation without regulatory risks.

Talk to QR Group

Does your company work with cosmetics and need to adapt to the new ANVISA rules?
Count on QR Group’s technical support to ensure compliance and security at every step.

Source: QR Group